J. H. Risse

640 total citations
19 papers, 449 citations indexed

About

J. H. Risse is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, J. H. Risse has authored 19 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in J. H. Risse's work include Radiopharmaceutical Chemistry and Applications (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). J. H. Risse is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). J. H. Risse collaborates with scholars based in Germany. J. H. Risse's co-authors include F. Grünwald, Hans Bender, Alfred Schmitz, Oliver Schmitt, H. Palmedo, Stefan Guhlke, G. Schoeneich, Frank Gr�nwald, H. J. Biersack and Christian Menzel and has published in prestigious journals such as Osteoporosis International, European Journal of Nuclear Medicine and Molecular Imaging and European Spine Journal.

In The Last Decade

J. H. Risse

19 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. H. Risse Germany 9 197 179 123 89 76 19 449
Jörn H. Risse Germany 10 192 1.0× 144 0.8× 76 0.6× 62 0.7× 91 1.2× 15 454
Bedii Kanmaz Türkiye 11 148 0.8× 147 0.8× 129 1.0× 171 1.9× 88 1.2× 28 476
G. Kumnig Austria 11 209 1.1× 308 1.7× 97 0.8× 126 1.4× 280 3.7× 17 648
I. Gómez Austria 11 164 0.8× 166 0.9× 72 0.6× 88 1.0× 264 3.5× 20 548
Osama Al‐Saif Saudi Arabia 11 168 0.9× 67 0.4× 197 1.6× 94 1.1× 118 1.6× 30 480
Leilei Yuan China 12 93 0.5× 105 0.6× 153 1.2× 117 1.3× 17 0.2× 33 493
Linda M. Thorson United States 7 124 0.6× 97 0.5× 29 0.2× 51 0.6× 85 1.1× 12 298
Fumito Fujiyoshi Japan 13 581 2.9× 79 0.4× 276 2.2× 188 2.1× 93 1.2× 20 683
Andreas Manouras Greece 12 232 1.2× 88 0.5× 68 0.6× 159 1.8× 11 0.1× 25 372
P D Radecki United States 10 246 1.2× 92 0.5× 38 0.3× 89 1.0× 110 1.4× 15 386

Countries citing papers authored by J. H. Risse

Since Specialization
Citations

This map shows the geographic impact of J. H. Risse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Risse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Risse more than expected).

Fields of papers citing papers by J. H. Risse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. H. Risse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Risse. The network helps show where J. H. Risse may publish in the future.

Co-authorship network of co-authors of J. H. Risse

This figure shows the co-authorship network connecting the top 25 collaborators of J. H. Risse. A scholar is included among the top collaborators of J. H. Risse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. H. Risse. J. H. Risse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ahmadzadehfar, Hojjat, Samer Ezziddin, Kai Wilhelm, et al.. (2014). Überlebenszeit nach Iod-131-markierter Lipiodol-Therapie des hepatozellulären Karzinoms. Nuklearmedizin - NuclearMedicine. 53(2). 46–53. 3 indexed citations
2.
Ezziddin, Samer, Kai Wilhelm, Rolf Fimmers, et al.. (2014). Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. Nuklearmedizin - NuclearMedicine. 53(2). 46–53. 5 indexed citations
3.
Ezziddin, Samer, K. Reichmann, Charlotte J. Yong‐Hing, et al.. (2013). Frühe Prädiktion des Ansprechens auf PRRT. Nuklearmedizin - NuclearMedicine. 52(5). 170–177. 8 indexed citations
4.
Reichmann, K., Charlotte J. Yong‐Hing, M. Damm, et al.. (2013). Early prediction of tumour response to PRRT. Nuklearmedizin - NuclearMedicine. 52(5). 170–177. 13 indexed citations
5.
Bucerius, Jan, et al.. (2007). Basedow-Struma mit papillärem Schilddrüsenkarzinom - Zufall oder Zusammenhang?. DMW - Deutsche Medizinische Wochenschrift. 132(18). 983–986. 3 indexed citations
6.
Pauleit, D., H. Palmedo, Hans Bender, et al.. (2007). Therapy of hepatocellular carcinoma with 131I-lipiodol: patient dosimetry. Nuklearmedizin - NuclearMedicine. 46(5). 192–197. 1 indexed citations
7.
Rabe, Christian, D. Pauleit, K. Reichmann, et al.. (2006). Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Nuklearmedizin - NuclearMedicine. 45(4). 185–192. 8 indexed citations
8.
Biersack, H. J., Samer Ezziddin, J. H. Risse, Hans Bender, & H. Palmedo. (2004). Therapie mit Radioisotopen in der Onkologie. Der Schmerz. 19(1). 9–17. 1 indexed citations
9.
Menzel, Christian, Uwe Berner, J. H. Risse, et al.. (2003). Monitoring the Efficacy of Iodine‐131‐MIBG Therapy using Fluorine‐18‐FDG‐PET. PubMed. 30(2). 37–40. 8 indexed citations
10.
Schmitz, Alfred, J. H. Risse, Johannes Textor, et al.. (2002). FDG-PET Findings of Vertebral Compression Fractures in Osteoporosis: Preliminary Results. Osteoporosis International. 13(9). 755–761. 71 indexed citations
11.
Kovács, Adorján F., et al.. (2001). Sentinel-Lymphknotenexstirpation. HNO. 49(8). 646–653. 21 indexed citations
12.
Schmitz, Alfred, et al.. (2001). Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. European Spine Journal. 10(6). 534–539. 81 indexed citations
13.
Heidenreich, Paul A., Roland Bares, Winfried Brenner, et al.. (2001). [Order of management for nuclear medicine for sentinel lymph node (SLN) diagnosis].. PubMed. 40(3). 98–101. 1 indexed citations
14.
Guhlke, Stefan, et al.. (2000). Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. European Journal of Nuclear Medicine and Molecular Imaging. 27(2). 123–130. 122 indexed citations
15.
Risse, J. H., et al.. (1999). I-131-Lipiodol Therapy in Liver Neoplasms. Hybridoma. 18(1). 83–85. 5 indexed citations
16.
Grünwald, F., Christian Menzel, Hans Bender, et al.. (1998). Redifferentiation therapy-induced radioiodine uptake in thyroid cancer.. PubMed. 39(11). 1903–6. 87 indexed citations
17.
Risse, J. H., P. Keulers, & René Günther. (1998). CT-gesteuerte perkutane Drainage retro- und extraperitonealer Abszesse und Flüssigkeitsverhalte. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 168(3). 281–286. 1 indexed citations
18.
Vorwerk, Dierk, et al.. (1995). Farbkodierte Duplexsonographie in der Erkennung von Nierenarterienstenosen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 162(5). 412–419. 6 indexed citations
19.
Hirche, Hj., et al.. (1987). Inotropic changes in ischaemic and non-ischaemic myocardium and arrhythmias within the first 120 minutes of coronary occlusion in pigs. Steinkopff eBooks. 82 Suppl 2. 301–310. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026